Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Volker Laux
Observed names:
Laux, Volker,
V Laux,
V. LAUX,
V. Laux
Institution:
Fraunhofer Institute for Translational Medicine and Pharmacology
Observed institutions:
Johannes Gutenberg University Mainz,
Fraunhofer Institute for Translational Medicine and Pharmacology,
Sanofi (Germany),
Bayer (Germany)
ORCID:
0000-0003-0891-3683
Observed ORCID:
0000-0003-0891-3683
OpenAlex ID:
A5045257458
Rivaroxaban: A New Oral Factor Xa Inhibitor
2010
·
Elisabeth Perzborn
, Susanne Roehrig
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
300
Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates
2013
·
András Gruber
, Hanna Tinel
, et al.
·
Thrombosis and Haemostasis
·
129
Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold: A Study Combining Structure-Activity Relationship and X-ray Crystallography
2005
·
Marc Nazaré
, David W. Will
, et al.
·
Journal of Medicinal Chemistry
·
125
Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa
2022
·
Stefan Heitmeier
, Mayken Visser
, et al.
·
Journal of Thrombosis and Haemostasis
·
116
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
2014
·
Elisabeth Perzborn
, Stefan Heitmeier
, et al.
·
Thrombosis Research
·
105
PDF
Effects of Rivaroxaban on Platelet Activation and Platelet–Coagulation Pathway Interaction: In Vitro and In Vivo Studies
2015
·
Elisabeth Perzborn
, Stefan Heitmeier
, et al.
·
Journal of Cardiovascular Pharmacology and Therapeutics
·
103
Preclinical and Clinical Characteristics of Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor
2007
·
Volker Laux
, Elisabeth Perzborn
, et al.
·
Seminars in Thrombosis and Hemostasis
·
91
Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran
2016
·
Peter Ellinghaus
, Elisabeth Perzborn
, et al.
·
Thrombosis Research
·
77
Direct inhibitors of coagulation proteins – the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
2009
·
Elisabeth Perzborn
, Stefan Heitmeier
, et al.
·
Thrombosis and Haemostasis
·
74
Structural Requirements for Factor Xa Inhibition by 3-Oxybenzamides with Neutral P1 Substituents: Combining X-ray Crystallography, 3D-QSAR, and Tailored Scoring Functions
2005
·
Hans Matter
, David W. Will
, et al.
·
Journal of Medicinal Chemistry
·
74
Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor‐induced hypercoagulability in vitro and in vivo
2014
·
E. Perzborn
, S. Heitmeier
, et al.
·
Journal of Thrombosis and Haemostasis
·
73
PDF
Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEG ylated recombinant factor VIII ( BAY 94‐9027) for haemophilia A
2014
·
J‐M. Gu
, P. Ramsey
, et al.
·
Haemophilia
·
73
Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra‐low‐molecular‐weight heparin, AVE5026
2009
·
C. VISKOV
, M. JUST
, et al.
·
Journal of Thrombosis and Haemostasis
·
63
Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX
2019
·
Mayken Visser
, René van Oerle
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
58
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cells
2022
·
Luise A. Roser
, Pelin Erkoc
, et al.
·
Biomedicine & Pharmacotherapy
·
43
PDF
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia
2020
·
Xiao-Yan Zhao
, Andreas Wilmen
, et al.
·
Nature Communications
·
43
PDF
Nrf2—A Molecular Target for Sepsis Patients in Critical Care
2020
·
Sandra Gunne
, Ulrike Heinicke
, et al.
·
Biomolecules
·
41
PDF
Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis
2012
·
E.M. BECKER
, E. PERZBORN
, et al.
·
Journal of Thrombosis and Haemostasis
·
39
Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism – results from clinical observation studies
2020
·
Marina Panova-Noeva
, Bianca Wagner
, et al.
·
EBioMedicine
·
37
A role for coagulation factor Xa in experimental pulmonary arterial hypertension
2011
·
Martina Delbeck
, Katrin F. Nickel
, et al.
·
Cardiovascular Research
·
36
Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription
2017
·
Chunyan Luo
, Elisabeth Pook
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
34
Emergence of new oral antithrombotics: a critical appraisal of their clinical potential
2008
·
Volker Laux
·
Vascular Health and Risk Management
·
34
PDF
Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism
2021
·
Vincent Ten Cate
, Jürgen H. Prochaska
, et al.
·
Blood
·
31
Inhibitory effects of pentoxifylline on LPS-induced leukocyte adhesion and macromolecular extravasation in the microcirculation
1995
·
D. Seiffge
, T. Bissinger
, et al.
·
Inflammation Research
·
27
Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment—From Mice to Men
2022
·
Andreas von Knethen
, Ulrike Heinicke
, et al.
·
Biomedicines
·
24
PDF
Show more works
View as search
Works count:
57
Citation count:
2,102
H-index:
24
I10-index:
38
Year
Topic
Type